• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. SFX SYM PDS+ UNI VIO 18IN 1 S/A CTX; SUTURE, SURGICAL, ABSORBABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. SFX SYM PDS+ UNI VIO 18IN 1 S/A CTX; SUTURE, SURGICAL, ABSORBABLE Back to Search Results
Model Number SXPP1A400
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Necrosis (1971)
Event Date 01/01/2022
Event Type  Injury  
Event Description
It was reported a patient underwent a total knee procedure on an unknown date in 2022 and barbed suture was used.Post-op, the patient had necrotic wound.Current patient status unknown.Additional information has been requested.
 
Manufacturer Narrative
(b)(4).Additional information has been requested and the following was received.If further details are received at a later date a supplemental medwatch will be sent.No additional information is available at this time.In what area or tissue was the severe necrotic tissue? patient experienced a mild case of necrosis, no additional information is available at this time.Is photo available of patient's necrosis? no.What was the procedure date? not provided.What date /day post op was the issue noted? was any prescription strength medication prescribed? please specify? was any surgical intervention performed to address necrosis? were any cultures taken? results? unknown.Patient demographics: initials / id, gender, age or date of birth; bmi.Patient pre-existing medical conditions (ie.Allergies, history of reactions): unknown.Name of surgeon? dr.(b)(6).Current patient status: unknown.In the manner the stratafix was used on each patient, is it believed to have contributed to necrosis? our belief is that the way the stratafix was ¿double backed¿ could have caused strangulation of the tissue which resulted in the necrosis.In the manner the stratafix was used on each patient, is it believed to have contributed to some other issue, please specify? (no response).No product is available for return.Note: events reported on: mw# 2210968-2023-00431, mw# 2210968-2023-00432.This is a combination product, and the event has been reviewed for both the suture and the triclosan.Trade name - irgacare®.Active ingredient(s) ¿ triclosan.Dosage form ¿ suture/solid/parenteral.Strength ¿ = 2360 ¿g/m.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Manufacturer Narrative
Product complaint # (b)(4).Note: events reported on: mw# 2210968-2023-00431, mw# 2210968-2023-00432, mw# 2210968-2023-00433, mw# 2210968-2023-00434, mw# 2210968-2023-00453.This is a combination product, and the event has been reviewed for both the suture and the triclosan.Trade name - irgacare®; active ingredient(s) ¿ triclosan; dosage form ¿ suture/solid/parenteral; strength ¿ = 2360 g/m.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SFX SYM PDS+ UNI VIO 18IN 1 S/A CTX
Type of Device
SUTURE, SURGICAL, ABSORBABLE
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON INC.-JUAREZ
avenida de las torres 7125
col salvacar
ciudad juarez 32604
MX   32604
Manufacturer Contact
elba bello
1000 route 202
raritan, NJ 08869
9083863534
MDR Report Key16216921
MDR Text Key307818445
Report Number2210968-2023-00434
Device Sequence Number1
Product Code NEW
UDI-Device Identifier10705031219366
UDI-Public10705031219366
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
K113004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 01/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/20/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberSXPP1A400
Device Catalogue NumberSXPP1A400
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received01/12/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-